Daily non-political popular news in brief.

Study: Directly observed HIV therapy for children is promising

The first study in the developing world of directly observed antiretroviral therapy for HIV-infected children shows this form of treatment is an inexpensive, effective way to ensure that children take life-saving medications. Researchers at the Warren Alpert Medical School of Brown University, together with Maryknoll, the international Catholic charity, conducted the study. Results are published in the June issue of the American Journal of Public Health.

Read more »

Keywords: study, directly, observed, hiv, therapy, children, promising

« Previous | Next »

Similar news on "Study: Directly observed HIV therapy for children is promising":

1. Research unveils new hope for deadly childhood disease
   12-12-2007 · EurekAlert!
   Investigators at the University of Rochester have uncovered a promising drug therapy that offers a ray of hope for children with Batten disease -- a rare neurodegenerative disease that strikes seemingly healthy kids, progressively robs them of their abilities to see, reason and move, and ultimately kills them in their young twenties. The study, highlighted in the January edition of Experimental Neurology, explains how investigators improved the motor skills of feeble mice that model the disease.
   Similar news · Read more »
   
2. Good outcomes possible for HIV-infected children in Africa enrolled in pediatric treatment programs
   10-22-2007 · EurekAlert!
   Care provided by nurses and other clinicians in primary health care settings in sub-Saharan Africa can result in good outcomes for children with HIV infection. But the death rate is high during the first 90 days of therapy, pointing to a need for early intervention, according to a study in the Oct. 24/31 issue of JAMA, a theme issue on poverty and human development.
   Similar news · Read more »
   
3. Treatment discovered for deadly childhood disease
   12-06-2006 · EurekAlert!
   Researchers have discovered that a treatment involving enzyme replacement therapy dramatically reduces the risk of death in children with Pompe disease, a rare genetic disorder in which most children die before their first birthday. The disorder causes profound muscle weakness and heart and breathing problems and affects as many as one in 40,000 births. The study is published in the online edition of Neurology, the scientific journal of the American Academy of Neurology.
   Similar news · Read more »
   
4. Certain combination therapy found more effective for treating malaria in African children
   05-22-2007 · EurekAlert!
   Ugandan children who received the combination therapy of artemether-lumefantrine experienced a lower rate of treatment failure compared to other combination therapies, according to a study in the May 23/30 issue of JAMA, a theme issue on malaria.
   Similar news · Read more »
   
5. St. Jude finds factors that accelerate resistance to targeted therapy in lymphoblastic leukemia
   08-29-2007 · EurekAlert!
   Results of a study by investigators at St. Jude Children’s Research Hospital provide strong evidence for why the targeted therapy drug, imatinib, or Gleevec™, which has revolutionized the treatment of chronic myelogenous leukemia, (CML) is often unable to prevent relapse of a particularly aggressive form of acute lymphoblastic leukemia (ALL).
   Similar news · Read more »
   
6. UF researchers track genetic journey of HIV from birth to death
   10-16-2007 · EurekAlert!
   University of Florida researchers tracked four children born with HIV, studying blood samples taken at birth, throughout life and just after death. Using a high-resolution computational technique, they monitored protein mutations. Previous studies relied on cell culture or animal models to follow the virus' mutations over time. The UF researchers are among the first groups to study the progression of HIV in human patients.
   Similar news · Read more »
   
7. Antenatal HIV
   11-21-2007 · EurekAlert!
   South Africa's Prevention of Mother to Child Transmission Program has severe shortcomings that could be doing more harm than good. HIV patients are missing out on opportunities to receive a key intervention -- namely the nevirapine tablet -- according to a study published in the online open access journal AIDS Research and Therapy.
   Similar news · Read more »
   
8. Promising drug combination may help those with ocular melanoma that has spread
   09-04-2007 · EurekAlert!
   A combination of two drugs shows promise in treating a rare and therapy-resistant type of melanoma that originates in the eye and spreads to other organs, according to a new study led by Duke University Comprehensive Cancer Center researchers.
   Similar news · Read more »
   
9. Replacing the cells lost in Parkinson disease
   12-03-2007 · EurekAlert!
   Parkinson disease is caused by the progressive degeneration of dopamine brain cells. Replacing these cells is considered a promising therapeutic strategy. Although DA cell-replacement therapy by transplantation of human fetal mesencephalic tissue has shown promise, limited tissue availability means other sources of these cells are needed. A recent study has described one new source for DA cells that provided marked benefit when transplanted into mice with a PD-like disease.
   Similar news · Read more »
   
10. Mayo Clinic study indicates medication for ADHD may help student outcomes
    09-18-2007 · EurekAlert!
    In an 18-year-study on attention-deficit/hyperactivity disorder, Mayo Clinic researchers found that treatment with prescription stimulants is associated with improved long-term academic success of children with ADHD. The Mayo Clinic results are the first population-based data to show stimulant drug therapy helps improve long-term school outcomes.
    Similar news · Read more »